JIN Historical Financial Ratios

ZJYL Stock

0.91 0.07 7.14%

JIN MEDICAL is lately reporting on over 85 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0, PTB Ratio of 0.39 or Days Sales Outstanding of 143 will help investors to properly organize and evaluate JIN MEDICAL INTERNATIONAL financial condition quickly.

Quick Ratio Current Ratio

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

About JIN Financial Ratios Analysis

JIN MEDICAL INTERNATIONALFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate JIN MEDICAL investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on JIN financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across JIN MEDICAL history.

JIN MEDICAL Financial Ratios Chart

At this time, JIN MEDICAL's POCF Ratio is quite stable compared to the past year. Capex To Operating Cash Flow is expected to rise to 0.03 this year, although the value of PTB Ratio will most likely fall to 0.39.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Revenue Per Share Price Cash Flow Ratio Asset Turnover

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing JIN MEDICAL INTERNATIONAL stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on JIN MEDICAL sales, a figure that is much harder to manipulate than other JIN MEDICAL INTERNATIONAL multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Revenue Per Share

The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.

Asset Turnover

The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.

Most ratios from JIN MEDICAL's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into JIN MEDICAL INTERNATIONAL current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

	2021	2022	2023	2024 (projected)
Days Sales Outstanding	80.87	156.53	180.01	142.82
PTB Ratio	0.21	0.35	0.41	0.39

Days Sales Outstanding Ptb Ratio

JIN MEDICAL fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		1.0	-0.54	-0.89	-0.54	-0.66	0.81	0.62	1.0	1.0	-0.64	0.92	0.19	-0.97	-0.54	-0.79	-0.47	0.8	-0.74	-1.0	-0.09	-0.9	-1.0	0.89	-0.84	0.9
Ptb Ratio	1.0		-0.55	-0.9	-0.53	-0.66	0.81	0.61	1.0	1.0	-0.65	0.93	0.18	-0.96	-0.54	-0.8	-0.46	0.79	-0.75	-1.0	-0.09	-0.91	-1.0	0.89	-0.84	0.91
Days Sales Outstanding	-0.54	-0.55		0.59	0.04	0.29	-0.5	0.25	-0.55	-0.53	0.27	-0.55	0.03	0.54	0.51	0.42	-0.04	0.02	0.57	0.56	-0.38	0.58	0.56	-0.42	0.4	-0.51
Book Value Per Share	-0.89	-0.9	0.59		0.44	0.68	-0.86	-0.33	-0.9	-0.89	0.66	-0.97	0.11	0.85	0.41	0.85	0.32	-0.65	0.97	0.91	0.22	0.89	0.91	-0.9	0.77	-0.91
Free Cash Flow Yield	-0.54	-0.53	0.04	0.44		0.92	-0.63	-0.51	-0.53	-0.54	0.92	-0.58	-0.35	0.41	0.42	0.34	0.63	-0.53	0.32	0.54	0.16	0.62	0.54	-0.41	0.88	-0.64
Operating Cash Flow Per Share	-0.66	-0.66	0.29	0.68	0.92		-0.85	-0.34	-0.66	-0.67	1.0	-0.76	-0.14	0.57	0.39	0.61	0.68	-0.53	0.6	0.67	0.28	0.77	0.67	-0.64	0.96	-0.83
Average Payables	0.81	0.81	-0.5	-0.86	-0.63	-0.85		0.26	0.81	0.81	-0.84	0.92	0.13	-0.76	-0.47	-0.86	-0.68	0.55	-0.8	-0.83	-0.27	-0.92	-0.83	0.85	-0.88	0.98
Capex To Depreciation	0.62	0.61	0.25	-0.33	-0.51	-0.34	0.26		0.61	0.62	-0.34	0.41	0.33	-0.6	-0.17	-0.35	-0.45	0.89	-0.13	-0.59	-0.24	-0.38	-0.59	0.5	-0.5	0.4
Pb Ratio	1.0	1.0	-0.55	-0.9	-0.53	-0.66	0.81	0.61		1.0	-0.65	0.93	0.18	-0.96	-0.54	-0.8	-0.46	0.79	-0.75	-1.0	-0.09	-0.91	-1.0	0.89	-0.84	0.91
Ev To Sales	1.0	1.0	-0.53	-0.89	-0.54	-0.67	0.81	0.62	1.0		-0.65	0.93	0.18	-0.96	-0.54	-0.8	-0.47	0.8	-0.74	-1.0	-0.1	-0.9	-1.0	0.9	-0.84	0.91
Free Cash Flow Per Share	-0.64	-0.65	0.27	0.66	0.92	1.0	-0.84	-0.34	-0.65	-0.65		-0.75	-0.14	0.56	0.38	0.6	0.68	-0.53	0.59	0.66	0.29	0.75	0.66	-0.63	0.95	-0.82
Roic	0.92	0.93	-0.55	-0.97	-0.58	-0.76	0.92	0.41	0.93	0.93	-0.75		0.1	-0.85	-0.57	-0.82	-0.44	0.66	-0.89	-0.94	-0.14	-0.97	-0.94	0.88	-0.86	0.96
Inventory Turnover	0.19	0.18	0.03	0.11	-0.35	-0.14	0.13	0.33	0.18	0.18	-0.14	0.1		-0.06	-0.64	0.2	-0.33	0.02	0.29	-0.17	0.56	-0.29	-0.17	-0.13	-0.24	0.13
Net Income Per Share	-0.97	-0.96	0.54	0.85	0.41	0.57	-0.76	-0.6	-0.96	-0.96	0.56	-0.85	-0.06		0.35	0.87	0.51	-0.82	0.71	0.96	0.22	0.79	0.96	-0.94	0.76	-0.86
Days Of Inventory On Hand	-0.54	-0.54	0.51	0.41	0.42	0.39	-0.47	-0.17	-0.54	-0.54	0.38	-0.57	-0.64	0.35		0.1	0.09	-0.09	0.29	0.55	-0.64	0.73	0.55	-0.2	0.52	-0.51
Payables Turnover	-0.79	-0.8	0.42	0.85	0.34	0.61	-0.86	-0.35	-0.8	-0.8	0.6	-0.82	0.2	0.87	0.1		0.63	-0.71	0.8	0.8	0.56	0.72	0.8	-0.98	0.69	-0.88
Average Inventory	-0.47	-0.46	-0.04	0.32	0.63	0.68	-0.68	-0.45	-0.46	-0.47	0.68	-0.44	-0.33	0.51	0.09	0.63		-0.55	0.19	0.46	0.5	0.46	0.46	-0.59	0.66	-0.65
Capex To Revenue	0.8	0.79	0.02	-0.65	-0.53	-0.53	0.55	0.89	0.79	0.8	-0.53	0.66	0.02	-0.82	-0.09	-0.71	-0.55		-0.49	-0.78	-0.5	-0.56	-0.78	0.82	-0.67	0.67
Cash Per Share	-0.74	-0.75	0.57	0.97	0.32	0.6	-0.8	-0.13	-0.75	-0.74	0.59	-0.89	0.29	0.71	0.29	0.8	0.19	-0.49		0.77	0.26	0.8	0.77	-0.81	0.65	-0.81
Pocfratio	-1.0	-1.0	0.56	0.91	0.54	0.67	-0.83	-0.59	-1.0	-1.0	0.66	-0.94	-0.17	0.96	0.55	0.8	0.46	-0.78	0.77		0.09	0.92	1.0	-0.9	0.85	-0.92
Interest Coverage	-0.09	-0.09	-0.38	0.22	0.16	0.28	-0.27	-0.24	-0.09	-0.1	0.29	-0.14	0.56	0.22	-0.64	0.56	0.5	-0.5	0.26	0.09		-0.03	0.09	-0.48	0.18	-0.25
Capex To Operating Cash Flow	-0.9	-0.91	0.58	0.89	0.62	0.77	-0.92	-0.38	-0.91	-0.9	0.75	-0.97	-0.29	0.79	0.73	0.72	0.46	-0.56	0.8	0.92	-0.03		0.92	-0.78	0.87	-0.95
Pfcf Ratio	-1.0	-1.0	0.56	0.91	0.54	0.67	-0.83	-0.59	-1.0	-1.0	0.66	-0.94	-0.17	0.96	0.55	0.8	0.46	-0.78	0.77	1.0	0.09	0.92		-0.9	0.85	-0.92
Days Payables Outstanding	0.89	0.89	-0.42	-0.9	-0.41	-0.64	0.85	0.5	0.89	0.9	-0.63	0.88	-0.13	-0.94	-0.2	-0.98	-0.59	0.82	-0.81	-0.9	-0.48	-0.78	-0.9		-0.75	0.9
Income Quality	-0.84	-0.84	0.4	0.77	0.88	0.96	-0.88	-0.5	-0.84	-0.84	0.95	-0.86	-0.24	0.76	0.52	0.69	0.66	-0.67	0.65	0.85	0.18	0.87	0.85	-0.75		-0.91
Roe	0.9	0.91	-0.51	-0.91	-0.64	-0.83	0.98	0.4	0.91	0.91	-0.82	0.96	0.13	-0.86	-0.51	-0.88	-0.65	0.67	-0.81	-0.92	-0.25	-0.95	-0.92	0.9	-0.91

Click cells to compare fundamentals

JIN MEDICAL Account Relationship Matchups

High Positive Relationship

Ptb Ratio	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Price To Sales Ratio
Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share

High Negative Relationship

Pfcf Ratio	- 1.0	Ev To Sales
Pocfratio	- 1.0	Ev To Sales
Pfcf Ratio	- 1.0	Pb Ratio
Pocfratio	- 1.0	Pb Ratio
Pfcf Ratio	- 1.0	Ptb Ratio
Pocfratio	- 1.0	Ptb Ratio

JIN MEDICAL fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	0.2	0.15	0.17	0.43	0.49	0.47
Ptb Ratio	0.29	0.23	0.21	0.35	0.41	0.39
Days Sales Outstanding	177.19	105.11	80.87	156.53	180.01	142.82
Book Value Per Share	1.35	1.75	1.9	3.3	2.97	3.12
Free Cash Flow Yield	0.74	1.82	0.48	0.35	0.32	0.39
Operating Cash Flow Per Share	(0.17)	0.31	0.73	0.2	0.43	0.39
Capex To Depreciation	0.43	0.12	0.11	0.5	0.58	0.35
Pb Ratio	0.29	0.23	0.21	0.35	0.41	0.39
Ev To Sales	0.26	(0.0237)	(0.084)	0.29	0.33	0.31
Free Cash Flow Per Share	(0.17)	0.3	0.73	0.19	0.41	0.37
Roic	0.16	0.17	0.14	0.0912	0.1	0.0996
Inventory Turnover	2.24	1.53	2.09	1.93	2.23	2.56
Net Income Per Share	0.28	0.33	0.34	0.4	0.36	0.24
Days Of Inventory On Hand	238.33	174.67	188.92	163.98	188.58	200.87
Payables Turnover	1.97	2.69	3.16	3.84	3.46	2.14
Sales General And Administrative To Revenue	0.0784	0.0924	0.0806	0.0969	0.0872	0.0697
Research And Ddevelopement To Revenue	0.0779	0.0755	0.0986	0.0778	0.0701	0.059
Capex To Revenue	0.008789	0.002065	0.002093	0.005748	0.00661	0.005733
Cash Per Share	0.35	0.72	0.88	2.3	2.07	2.17
Pocfratio	1.27	0.54	2.01	2.73	2.46	2.58
Capex To Operating Cash Flow	0.0569	0.007339	0.0254	0.0367	0.033	0.0347
Pfcf Ratio	1.35	0.55	2.06	2.84	2.55	2.68
Days Payables Outstanding	185.45	135.61	115.57	94.94	109.19	161.35
Income Quality	1.13	2.22	0.58	1.08	0.97	0.54
Roe	0.2	0.19	0.18	0.12	0.14	0.26
Ev To Operating Cash Flow	1.66	(0.0842)	(1.02)	1.83	1.64	1.73
Pe Ratio	1.44	1.21	1.17	2.95	3.39	3.22
Return On Tangible Assets	0.11	0.12	0.13	0.0879	0.1	0.15
Ev To Free Cash Flow	1.76	(0.0849)	(1.05)	1.9	1.71	1.79
Earnings Yield	0.69	0.83	0.85	0.34	0.31	0.52
Intangibles To Total Assets	0.00869	0.008452	0.007794	0.004691	0.005395	0.008887
Net Debt To E B I T D A	0.35	(1.14)	(1.55)	(0.91)	(1.05)	(1.1)
Current Ratio	1.81	2.47	3.31	3.49	3.14	1.94
Tangible Book Value Per Share	1.33	1.73	1.88	3.28	2.95	3.1
Receivables Turnover	2.06	3.47	4.51	2.33	2.1	2.42
Graham Number	2.89	3.6	3.81	5.43	4.89	2.6
Shareholders Equity Per Share	1.35	1.75	1.9	3.3	2.97	3.12

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:

How To Invest In JIN

Details

Is JIN Stock a good investment?

Details

What is JIN MEDICAL's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.12)

Earnings Share

0.02

Revenue Per Share

0.129

Quarterly Revenue Growth

0.03

Return On Assets

0.0403

The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

JIN Historical Financial Ratios

About JIN Financial Ratios Analysis

JIN MEDICAL Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Revenue Per Share

Asset Turnover

JIN MEDICAL fundamentals Correlations

JIN MEDICAL Account Relationship Matchups

High Positive Relationship

High Negative Relationship

JIN MEDICAL fundamentals Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY